Condition
Vagal Nerve Stimulation
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed3
Terminated1
Not Yet Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07253961Not ApplicableNot Yet Recruiting
Cold-Induced Vagal Stimulation for Attenuating Venipuncture Pain in Obese Individuals
NCT06662422Not ApplicableCompleted
Auricular Neuromodulation for FESS
NCT06499662Not ApplicableCompleted
Randomised Clinical Trial to Determine the Effect of Vagus Nerve Neurodynamics on the Neurovegetative Nerve System in People With Chronic Stress.
NCT03908073Not ApplicableTerminated
Electrical Vagal Nerve Stimulation in Ulcerative Colitis
NCT04896424Not ApplicableCompletedPrimary
Vagal Response and Cardiac Autonomic Modulation. Insides From Cryoballoon Ablation
Showing all 5 trials